Skeletal metastases in oncology patients are identified by Bone scan and/Positron Emission Tomography (PET) scan. But developing countries in the world still lack adequate numbers of these imaging facilities. Aims Since Magnetic Resonance Imaging (MRI) is widely available as compared to bone scan or PET scan; a double blind study was undertaken to see if whole body imaging with MRI can give an idea of skeletal metastases. Method Diffusion weighted whole body Magnetic Resonance Imaging with background body signal suppression (DWIBS) was performed using 1.5 Tesla (T) MRI on histopathologically proven cases of carcinoma of breast within two months of mastectomy and followed up after a year of surgery. Similarly bone scan was also performed in these patients. Results DWIBS MRI demonstrated the presence and extent of bone metastases in 10 out of a total 18 patients included in study while bone scan could demonstrate them in only three cases. A highly significant difference between proportions of the skeletal metastases detected by whole body DWIBS-MRI than that by bone scan at one year follow-up. (i.e. p<0.01, z=2.66) was seen.
1. The knowledge about the presence and extent of fresh or pre-existing skeletal metastases in oncology patients; significantly modifies management. 2. Like PET scan or bone scan, DWIBS MRI too can satisfactorily demonstrate skeletal metastases. 3. DWIBS MRI scores over bone scan; not only in demonstrating skeletal metastases but also in terms of wide scale availability of MRI and lack of radiation exposure in MRI.
Background
Malignancies in their diverse forms not only cause mortality and morbidity but also adversely affect the entire family of the afflicted. Prompt diagnosis, staging and identification of metastases at the earliest are the essential steps for timely management and a positive outcome.
Skeletal metastases are ruled out by whole body imaging that is primarily done either by bone scan or by PET scan. These imaging modalities are not widely available in developing countries and patients are frequently forced to wait. Also, there is radiation exposure to these patients who are already weakened by malignancies as well as by chemotherapy regimens. As MRI has the potential to detect metastatic lesions even before changes in bone metabolism make them detectable on bone scan; 1 we decided to use a MRI-based whole body imaging technique called DWIBS to identify skeletal metastases and to compare it with results of bone scan. On bone scan skeletal metastases are demonstrated as areas of increased uptake; whereas on DWIBS MRI, these are seen as focal hypo intensities.
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Method
The study was carried out at the Rural Medical College, of Pravara Institute of Medical Sciences, Loni, Maharashtra, India, using 1.5 T MRI system. Permission of institutional ethical and research cell, and informed written consent from patients were obtained prior to study. Claustrophobic patients and those with general contra-indications for MRI study were excluded. All patients with mastectomy positive for breast carcinoma were included following surgery to assess for skeletal metastases first within three months of surgery and later at a 12 month interval. Bone scan was also done in these patients within a week of DWIBS MRI. Parameters used for DWIBS protocol at our institute are shown in Table 1 . Axial slices were reformatted to produce whole body image demonstrated with inversion of grey scale so that the final images resemble bone scan or PET scan-like images which are now well accepted by referring physicians and surgeons. (Figure 1 ) demonstrated normal hypo intense appearance in brain, central spinal canal, stomach, spleen and pelvis. 1, 3 But when skeletal metastases were present, prominent hypo intense areas were seen in the involved portion of skeleton. Tiny to large hypo intensities in lymph nodal regions in cases with nodal spread and hypo intensities in viscera like liver and spleen would be seen in cases with visceral spread. Out of the total of 18 patients referred for DWIBS Study, 10 showed skeletal metastases on DWIBS, and only three of these 10 showed skeletal metastases on bone scan as shown in Table 2 . By applying Z test of difference between two proportions there was a highly significant difference between proportions of skeletal metastasis detected by whole body DWIBS-MRI than that by bone scan at one year follow-up.(i.e. p<0.01). And there was no significant difference between proportions of skeletal metastasis at immediate post-operative period as seen on whole body DWIBS-MRI and that on bone scan (i.e. p>0.05).
Results
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Hence DWIBS was more sensitive that bone scan in detecting skeletal metastases. Representative and comparative images are shown in Figures 2a and 2b respectively.
Discussion
At present, oncoimaging for skeletal metastasis relies entirely on bone scan or PET scan for whole body imaging; although there are concerns about radiation hazards, economic constraints, scarce availability and prolonged waiting periods. DWIBS MRI can be an effective alternative especially where bone scan or PET scan is not available.
Areas with restricted diffusion occur in tumours due to high cellularity and many cellular membranes and; appears bright on diffusion weighted MRI. However, conventionally these images are printed with inversion of grey scale so that they resemble bone scan images as these are well accepted by treating doctors.
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Our initial results with DWIBS have been well accepted by the referring doctors. In fact when we analyse, compare and contrast various imaging techniques for evaluating skeletal metastases as shown in Table 3 , we feel that DWIBS MRI is a viable alternative especially for developing countries where the availability of MRI facility is common than bone scan or PET scan. Discrepancy between PET scan and bone scan to detect bone metastases has been reported. 5, 6 Negative scintigraphy with positive magnetic resonance imaging in bone metastases has also been reported. 7, 8 Hence wide comparative studies between DWIBS, bone scan and PET scan are needed. 9,10,11 DWIBS, an MRI similar to 18F-FDG PET/CT imaging, seems to be feasible in the detection of cancers; however it may be difficult to differentiate between the benign and malignant lesions.
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DWIBS is thus an upcoming MRI modality for cancer imaging wherever bone scan or PET scan is not available and cost is an issue. Moreover, DWIBS can be performed on state-ofthe-art MRI systems supplied by all major vendors.
The future prospects include comparative studies for the assessment of therapeutic response through Radiological and Nuclear Medicine Imaging Modalities, effective treatment of which is the final goal in managing skeletal metastases.
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Our initial results prove that DWIBS is a good alternative for whole body imaging to assess metastases and help in staging of cancer patients. It is radiation free, widely available and cost efficient. Hence we suggest that it be used more often, although comparative studies with bone scan and PET scan would help in establishing statistical details about sensitivity and specificity of each modality as compared to DWIBS.
Conclusion
Due to economic constraints in developing nations, not all patients can afford the costly cancer treatment and imaging assessment. Advanced Imaging with PET-CT & bone scan therefore remains a distant dream. DWIBS MRI promises a viable alternative to this necessity. 
